Fomiroid A, a novel compound from the mushroom Fomitopsis nigra, inhibits NPC1L1-mediated cholesterol uptake via a mode of action distinct from that of ezetimibe.
Hypercholesterolemia is one of the key risk factors for coronary heart disease, a major cause of death in developed countries. Suppression of NPC1L1-mediated dietary and biliary cholesterol absorption is predicted to be one of the most effective ways to reduce the risk of hypercholesterolemia. In a...
Main Authors: | Tomohiro Chiba, Tsuyoshi Sakurada, Rie Watanabe, Kohji Yamaguchi, Yasuhisa Kimura, Noriyuki Kioka, Hirokazu Kawagishi, Michinori Matsuo, Kazumitsu Ueda |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4281142?pdf=render |
Similar Items
-
ATPase activity of human ABCG1 is stimulated by cholesterol and sphingomyelin[S]
by: Hiroshi Hirayama, et al.
Published: (2013-02-01) -
Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestine
by: Chang Xie 谢畅, et al.
Published: (2012-10-01) -
DNA protective activity of triterpenoids isolated from medicinal mushroom Fomitopsis betulina
by: Sofrenić Ivana V., et al.
Published: (2021-01-01) -
ATP hydrolysis-dependent conformational changes in the extracellular domain of ABCA1 are associated with apoA-I binding[S]
by: Kohjiro Nagao, et al.
Published: (2012-01-01) -
<it>NPC1L1 </it>haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe
by: Guy Justin, et al.
Published: (2005-08-01)